日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease

临床前药代动力学/药效学研究阐明了乙胺丁醇在堪萨斯分枝杆菌肺病中的作用

Gumbo, Tawanda; Boorgula, Gunavanthi D; Srivastava, Shashikant

Eravacycline pharmacokinetics/pharmacodynamics in the hollow fiber system model of Mycobacterium abscessus lung disease

在脓肿分枝杆菌肺病的空心纤维系统模型中,依拉环素的药代动力学/药效学研究

Singh, Sanjay; Shrivastava, Avneesh; Boorgula, Gunavanthi D; Long, Mary C; Robbins, Brian; Gumbo, Tawanda; Srivastava, Shashikant

Preclinical evaluation of epetraborole in the hollow fibre system model of Mycobacterium abscessus lung disease

在脓肿分枝杆菌肺病的空心纤维系统模型中对依佩曲硼罗进行临床前评价

Singh, Sanjay; Boorgula, Gunavanthi D; Nguyen, Minh-Vu H; Daley, Charles L; Gumbo, Tawanda; Srivastava, Shashikant

Novel regimens for treatment of Mycobacterium avium lung disease based on advanced in vitro systems and the mathematics of basis functions

基于先进体外系统和基函数数学的新型鸟分枝杆菌肺病治疗方案

Srivastava, Shashikant; Singh, Sanjay; Boorgula, Gunavanthi D; McShane, Pamela J; Gumbo, Tawanda

Imipenem Pharmacokinetics/Pharmacodynamics in Preclinical Hollow Fiber Model, Dose Finding in Virtual Patients, and Clinical Evidence of Efficacy for Mycobacterium abscessus Lung Disease

亚胺培南在临床前中空纤维模型中的药代动力学/药效学、虚拟患者的剂量探索以及治疗脓肿分枝杆菌肺病的临床疗效证据

Singh, Sanjay; Gumbo, Tawanda; Wang, Jann-Yuan; Boorgula, Gunavanthi D; Burke, Andrew; Huang, Hung-Ling; McShane, Pamela J; Amaro-Galvez, Rodolfo; Gross, Jane E; Aryal, Santosh; Heysell, Scott K; Srivastava, Shashikant

Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis

在异质性耐药结核病背景下,氟喹诺酮类药物和利福平联合用药

Vogensen, Vanessa B; Singh, Sanjay; Allende, Christopher J; Engelthaler, David M; Boorgula, Gunavanthi D; Thomas, Tania A; Sturkenboom, Marieke G G; Akkerman, Onno W; Gumbo, Tawanda; Srivastava, Shashikant

Ivacaftor affects the susceptibility of standard-of-care drugs used to treat Mycobacterium abscessus lung disease

伊伐卡托会影响用于治疗脓肿分枝杆菌肺病的标准治疗药物的敏感性。

Shrivastava, Avneesh; Singh, Sanjay; Boorgula, Gunavanthi D; Galvez, Rodolfo-Amaro; Srivastava, Shashikant

A mechanistic understanding of the effect of Staphylococcus aureus VraS histidine kinase single-point mutation on antibiotic resistance

对金黄色葡萄球菌VraS组氨酸激酶单点突变影响抗生素耐药性的机制研究

Ali, Liaqat; Karki, Salima; Boorgula, Gunavanthi D; Mekakda, Amir; Cagle-White, Brittnee; Bhattarai, Shrijan; Beaudoin, Robert; Blakeney, Aryanna; Singh, Sanjay; Srivastava, Shashikant; Abdel Aziz, May H

Sulbactam-durlobactam improves cephalosporin and carbapenem susceptibility and time-kill effect against Mycobacterium abscessus

舒巴坦-度洛巴坦可提高头孢菌素和碳青霉烯类抗生素对脓肿分枝杆菌的敏感性,并延长其杀菌时间。

Shrivastava, Avneesh; Boorgula, Gunavanthi D; Singh, Sanjay; Stiles, Danaleigh; McShane, Pamela J; Devine, Megan; Gumbo, Tawanda; Srivastava, Shashikant

P12.09.B ROLE OF CARBOHYDRATE-BINDING PROTEINS IN CONTROLLING GLIOBLASTOMA STEM CELL FATE AND TUMORIGENESIS

P12.09.B 碳水化合物结合蛋白在控制胶质母细胞瘤干细胞命运和肿瘤发生中的作用

Ali, Liaqat; Karki, Salima; Boorgula, Gunavanthi D; Mekakda, Amir; Cagle-White, Brittnee; Bhattarai, Shrijan; Beaudoin, Robert; Blakeney, Aryanna; Singh, Sanjay; Srivastava, Shashikant; Abdelaziz, May H; Loor, Juan; Rashad, S; Zhang, T; Mousa, A; Niizuma, K; Sliusar, M; Souleyreau, W; Guedon, L; Burban, A; Sharanek, A; Bikfalvi, A